Functional and molecular aspects of transient T cell unresponsiveness: Role of selective interleukin-2 deficiency

Clinical and Experimental Immunology

Volumn 132, Issue 2, 2003, Pages 225-231

  Köller, Marcus D ^a   Kiener, H P ^a   Aringer, M ^a   Graninger, W B ^a   Meuer, S ^b   Samstag, Y ^b   Smolen, J S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Anergy; Cellular activation; Suppression; T lymphocytes; Tolerance

Indexed keywords

CD3 ANTIGEN; CONCANAVALIN A; DEOXYRIBOSE; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGENIC AGENT; PHYTOHEMAGGLUTININ; PROTEIN; PROTEIN P56; T LYMPHOCYTE RECEPTOR; TRANSFERASE; UNCLASSIFIED DRUG; ZETA CHAIN PROTEIN;

APOPTOSIS; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MOLECULAR BIOLOGY; MONONUCLEAR CELL; NICK END LABELING; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; APOPTOSIS; AUTOIMMUNE DISEASES; CARRIER PROTEINS; CELL DIVISION; CELLS, CULTURED; CONCANAVALIN A; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNE TOLERANCE; IMMUNOGLOBULIN GAMMA-CHAINS; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MITOGEN-ACTIVATED PROTEIN KINASES; PHYTOHEMAGGLUTININS; PROTEINS; RECEPTORS, INTERLEUKIN-2; RNA, MESSENGER; T-LYMPHOCYTES; TIME FACTORS;

EID: 0038216945     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02150.x     Document Type: Article

References (25)

1. Meuer SC, Hussey RE, Cantrell DA et al. Triggering of the T3-Ti antigen receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway. Proc Natl Acad Sci USA 1984; 81:1509-13.
2. Leonard WJ, Kronke M, Peffer NJ, Depper JM, Greene WC. Interleukin 2 receptor gene expression in normal human T lymphocytes. Proc Natl Acad Sci USA 1985; 82:6281-5.
3. Chatila TA, Schwartz DH, Miller R, Geha RS. Requirement for mitogen, T cell-accessory cell contact, and interleukin 1 in the induction of resting T-cell proliferation. Clin Immunol Immunopathol 1987; 44:235-47.
4. Cantrell DA, Collins MK, Crumpton MJ. Autocrine regulation of T-lymphocyte proliferation: differential induction of IL-2 and IL-2 receptor. Immunology 1988; 65:343-9.
5. Taams LS, van Rensen AJ, Poelen MC et al. Anergic T cells actively suppress T cell responses via the antigen-presenting cell. Eur J Immunol 1998; 28:2902-12.
6. Davis L, Vida R, Lipsky PE. Regulation of human T lymphocyte mitogenesis by antibodies to CD3. J Immunol 1986; 137:3758-67.
7. Hollsberg P, Batra V, Dressel A, Hafler DA. Induction of anergy in CD8 T cells by B cell presentation of antigen. J Immunol 1996; 157:5269-76.
8. + T cells by staphylococcal enterotoxin B. J Exp Med 1990; 172:1091-100.
9. Kyburz D, Aichele P, Speiser DE, Hengartner H, Zinkernagel RM, Pircher H. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur J Immunol 1993; 23:1956-62.
10. Koller M, Aringer M, Kiener H et al. Expression of adhesion molecules on synovial fluid and peripheral blood monocytes in patients with inflammatory joint disease and osteoarthritis. Ann Rheum Dis 1999; 58:709-12.
11. Kiener HP, Hofbauer R, Tohidast-Akrad M et al. Tumor necrosis factor alpha promotes the expression of stem cell factor in synovial fibroblasts and their capacity to induce mast cell chemotaxis. Arthritis Rheum 2000; 43:164-74.
12. Schroder AJ, Quehl P, Muller J, Samstag Y. Conversion of p56 (lck) to p60 (lck) in human peripheral blood T lymphocytes is dependent on co-stimulation through accessory receptors: involvement of phospholipase C, protein kinase C and MAP-kinases in vivo. Eur J Immunol 2000; 30:635-43.
13. Takahashi S, Maecker HT, Levy R. DNA fragmentation and cell death mediated by T cell antigen receptor/CD3 complex on a leukemia T cell line. Eur J Immunol 1989; 19:1911-9.
14. Rocha B, Tanchot C, Von Boehmer H. Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen. J Exp Med 1993; 177:1517-21.
15. De Mattia F, Chomez S, Van Laethem F et al. Antigen-experienced T cells undergo a transient phase of unresponsiveness following optimal stimulation. J Immunol 1999; 163:5929-36.
16. Tham EL, Shrikant P, Mescher MF. Activation-induced nonresponsiveness: a Th-dependent regulatory checkpoint in the CTL response. J Immunol 2002; 168:1190-7.
17. + T cells become nonresponsive (anergic) following activation in the presence of costimulation. J Immunol 1999; 163:102-10.
18. Tham EL, Mescher MF. Signaling alterations in activation-induced nonresponsive CD8 T cells. J Immunol 2001; 167:2040-8.
19. Davis LS, Wacholtz MC, Lipsky PE. The induction of T cell unresponsiveness by rapidly modulating CD3. J Immunol 1989; 142:1084-94.
20. Lee JE, Cossoy MB, Chau LA, Singh B, Madrenas J. Inactivation of lck and loss of TCR-mediated signaling upon persistent engagement with complexes of peptide MHC molecules. J Immunol 1997; 159:61-9.
21. Sido B, Braunstein J, Breitkreutz R, Herfarth C, Meuer SC. Thiol-mediated redox regulation of intestinal lamina propria T lymphocytes. J Exp Med 2000; 192:907-12.
22. + suppressor T cells. Immunol Rev 2001; 182:58-67.
23. Trimble LA, Shankar P, Patterson M, Daily JP, Lieberman J. Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation. J Virol 2000; 74:7320-30.
24. Bermas BL, Petri M, Goldman D et al. T helper cell dysfunction in systemic lupus erythematosus (SLE): relation to disease activity. J Clin Immunol 1994; 14:169-77.
25. Solomou EE, Juang YT, Gourlry MF, Kammer GM, Tsokos GC. Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. J Immunol 2001; 166:4216-22.